Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Feifei Pu, Fengxia Chen, Zhicai Zhang, Jianxiang Liu & Zengwu Shao. (2020) Information Transfer and Biological Significance of Neoplastic Exosomes in the Tumor Microenvironment of Osteosarcoma. OncoTargets and Therapy 13, pages 8931-8940.
Read now
Read now
Chiara Secondini, Oriana Coquoz, Lorenzo Spagnuolo, Thibaud Spinetti, Sanam Peyvandi, Laura Ciarloni, Francesca Botta, Carole Bourquin & Curzio Rüegg. (2017) Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade. OncoImmunology 6:6.
Read now
Read now
Ibrahim H. Younos, Fuminori Abe & James E. Talmadge. (2015) Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets. Leukemia & Lymphoma 56:8, pages 2251-2263.
Read now
Read now
Fabrizio Mattei, Giovanna Schiavoni, Adele De Ninno, Valeria Lucarini, Paola Sestili, Antonella Sistigu, Alessandra Fragale, Massimo Sanchez, Massimo Spada, Annamaria Gerardino, Filippo Belardelli, Luca Businaro & Lucia Gabriele. (2014) A multidisciplinary study using in vivo tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cells. Journal of Immunotoxicology 11:4, pages 337-346.
Read now
Read now
Anandi Sawant & Selvarangan Ponnazhagan. (2013) Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease. OncoImmunology 2:5.
Read now
Read now
Articles from other publishers (95)
Gwenyth J. Joseph, Douglas B. Johnson & Rachelle W. Johnson. (2023) Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms. Journal of Bone Oncology 43, pages 100505.
Crossref
Crossref
Paolo Giannoni, Cecilia Marini, Giovanna Cutrona, Gian Mario Sambuceti, Franco Fais & Daniela de Totero. (2023) Unraveling the Bone Tissue Microenvironment in Chronic Lymphocytic Leukemia. Cancers 15:20, pages 5058.
Crossref
Crossref
Haoyu Liu, Zhicheng Wang, Yuntao Zhou & Yanming Yang. (2023) MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target. Frontiers in Immunology 14.
Crossref
Crossref
Yi Ren, Henrik Bäcker, Michael Müller & Arne Kienzle. (2023) The role of myeloid derived suppressor cells in musculoskeletal disorders. Frontiers in Immunology 14.
Crossref
Crossref
Kyu Hwan Kwack, Lixia Zhang & Keith L. Kirkwood. 2023.
Arundhati Mehta, Shiv Govind Rawat, Yashwant Ratre, Vivek Soni, Dhananjay Shukla, Ajay Kumar & Naveen Vishvakarma. 2023. Immunological Implications and Molecular Diagnostics of Genitourinary Cancer. Immunological Implications and Molecular Diagnostics of Genitourinary Cancer
153
180
.
Fang Qiu, Jie Huang, Xuekun Fu & Chao Liang. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
26
.
Morten F. Gjerstorff, Sofie Traynor, Odd L. Gammelgaard, Simone Johansen, Christina B. Pedersen, Henrik J. Ditzel & Mikkel G. Terp. (2022) PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer. Cancers 14:24, pages 6153.
Crossref
Crossref
Paolo Giannoni, Cecilia Marini, Giovanna Cutrona, Katia Todoerti, Antonino Neri, Adalberto Ibatici, Gianmario Sambuceti, Simona Pigozzi, Marco Mora, Manlio Ferrarini, Franco Fais & Daniela de Totero. (2022) A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation. Cancers 14:23, pages 5979.
Crossref
Crossref
Ryan D. Calvert, James C. Fleet, Pierrick G. J. Fournier, Patricia Juarez, Grant N. Burcham, Jessica M. Haverkamp, Theresa A. Guise, Timothy L. Ratliff & Bennett D. Elzey. (2022) Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity. ImmunoHorizons 6:12, pages 790-806.
Crossref
Crossref
Giulia Bertolini & Ilaria Roato. (2022) The road of NSCLC stem cells toward bone metastases. Bone Reports 17, pages 101619.
Crossref
Crossref
Lin Zou, Wangsheng Jiang, Zihan Wang, Jianting Chen & Siyuan Zhu. (2022) Effect of Advanced Oxidation Protein Products (AOPPs) and aging on the osteoclast differentiation of Myeloid-Derived Suppressor Cells (MDSCs) and its preliminary mechanism. Biochemical and Biophysical Research Communications 636, pages 87-96.
Crossref
Crossref
Lulian Pang, Chen Gan, Jian Xu, Yingxue Jia, Jiaying Chai, Runze Huang, Anlong Li, Han Ge, Sheng Yu & Huaidong Cheng. (2022) Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies. Cancers 14:23, pages 5727.
Crossref
Crossref
Claire L. Ihle, Sabrina J. Wright-Hobart & Philip Owens. (2022) Therapeutics targeting the metastatic breast cancer bone microenvironment. Pharmacology & Therapeutics 239, pages 108280.
Crossref
Crossref
Yunfei He, Wenqian Luo, Yingjie Liu, Yuan Wang, Chengxin Ma, Qiuyao Wu, Pu Tian, Dasa He, Zhenchang Jia, Xianzhe Lv, Yu-Shui Ma, Haitang Yang, Ke Xu, Xue Zhang, Yansen Xiao, Peiyuan Zhang, Yajun Liang, Da Fu, Feng Yao & Guohong Hu. (2022) IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer. Journal of Clinical Investigation 132:20.
Crossref
Crossref
Alexis Wilson, Laimar C. Garmo & Izabela Podgorski. (2022) Interplay between fat cells and immune cells in bone: Impact on malignant progression and therapeutic response. Pharmacology & Therapeutics 238, pages 108274.
Crossref
Crossref
Ningning He & Jingting Jiang. (2022) Contribution of immune cells to bone metastasis pathogenesis. Frontiers in Endocrinology 13.
Crossref
Crossref
Danna L. Arellano, Patricia Juárez, Andrea Verdugo‐Meza, Paloma S. Almeida‐Luna, Juan A. Corral‐Avila, Florian Drescher, Felipe Olvera, Samanta Jiménez, Bennett D. Elzey, Theresa A. Guise & Pierrick G.J. Fournier. (2022) Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice. Journal of Bone and Mineral Research 37:8, pages 1446-1463.
Crossref
Crossref
Noriko Takegahara, Hyunsoo Kim & Yongwon Choi. (2022) RANKL biology. Bone 159, pages 116353.
Crossref
Crossref
Bo Li, Pengru Wang, Jian Jiao, Haifeng Wei, Wei Xu & Pingting Zhou. (2022) Roles of the RANKL–RANK Axis in Immunity—Implications for Pathogenesis and Treatment of Bone Metastasis. Frontiers in Immunology 13.
Crossref
Crossref
Céline Blaye, Thomas Boyer, Florent Peyraud, Charlotte Domblides & Nicolas Larmonier. (2022) Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers. Frontiers in Immunology 13.
Crossref
Crossref
Marie Muller, Vincent Haghnejad, Marion Schaefer, Guillaume Gauchotte, Bénédicte Caron, Laurent Peyrin-Biroulet, Jean-Pierre Bronowicki, Cindy Neuzillet & Anthony Lopez. (2022) The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges. Cancers 14:4, pages 995.
Crossref
Crossref
Carey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, Dominic T Moore, Maria J Sambade, Sonia Laurie, Alexander Robeson, Oleg Kolupaev, Luz A Cuaboy, Amy L Garrett, Karen McKinnon, Kristen Cowens, Dante Bortone, Benjamin C Calhoun, Alec D Wilkinson, Lisa Carey, Trevor Jolly, Hyman Muss, Katherine Reeder-Hayes, Rebecca Kaltman, Rachel Jankowitz, Vinay Gudena, Oludamilola Olajide, Charles Perou, E Claire Dees, Benjamin G Vincent & Jonathan S Serody. (2022) Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal for ImmunoTherapy of Cancer 10:2, pages e003427.
Crossref
Crossref
Rachelle W. Johnson, Julie Rhoades & T. John Martin. 2022. Parathyroid Hormone. Parathyroid Hormone
215
230
.
Hector M. Arredondo Carrera & Ning Wang. 2022. Bone Cancer. Bone Cancer
393
410
.
Christopher George, Nichole Michael & Penelope D. Ottewell. 2022. Bone Cancer. Bone Cancer
121
128
.
Julia Halper, Maria-Bernadette Madel & Claudine Blin-Wakkach. 2022. Bone Cancer. Bone Cancer
179
188
.
Zhiguo Ling, Chuan Yang, Jiulin Tan, Ce Dou & Yueqi Chen. (2021) Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases. Cellular and Molecular Life Sciences 78:23, pages 7161-7183.
Crossref
Crossref
Xinyu Cheng & Zhan Wang. (2021) Immune Modulation of Metastatic Niche Formation in the Bone. Frontiers in Immunology 12.
Crossref
Crossref
Zhaofei Li, Yanfang Zhao, Zhu Chen, Jannet Katz, Suzanne M. Michalek, Yuhong Li & Ping Zhang. (2021) Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells. Molecular Immunology 137, pages 187-200.
Crossref
Crossref
Lorenz C. Hofbauer, Aline Bozec, Martina Rauner, Franz Jakob, Sven Perner & Klaus Pantel. (2021) Novel approaches to target the microenvironment of bone metastasis. Nature Reviews Clinical Oncology 18:8, pages 488-505.
Crossref
Crossref
Meghan J. O’Melia, Margaret P. Manspeaker & Susan N. Thomas. (2021) Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC. Cancer Immunology, Immunotherapy 70:8, pages 2179-2195.
Crossref
Crossref
Philippe Clézardin, Rob Coleman, Margherita Puppo, Penelope Ottewell, Edith Bonnelye, Frédéric Paycha, Cyrille B. Confavreux & Ingunn Holen. (2021) Bone metastasis: mechanisms, therapies, and biomarkers. Physiological Reviews 101:3, pages 797-855.
Crossref
Crossref
Tiina E. Kähkönen, Jussi M. Halleen & Jenni Bernoulli. (2021) Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis. Cells 10:6, pages 1529.
Crossref
Crossref
Julia N. Cheng, Jennifer B. Frye, Susan A. Whitman, Andrew G. Kunihiro, Ritu Pandey & Janet L. Funk. (2021) A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression. International Journal of Molecular Sciences 22:9, pages 4463.
Crossref
Crossref
Courtney M. Edwards & Rachelle W. Johnson. (2021) From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression. Frontiers in Oncology 11.
Crossref
Crossref
Domenica Giannandrea, Valentina Citro, Elena Lesma, Monica Bignotto, Natalia Platonova & Raffaella Chiaramonte. (2021) Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis. Frontiers in Oncology 11.
Crossref
Crossref
Elham Safarzadeh, Ali Mohammadi, Behzad Mansoori, Pascal H. G. Duijf, Shahryar Hashemzadeh, Vahid Khaze, Tohid Kazemi, Afshin Derakhshani, Nicola Silvestris & Behzad Baradaran. (2021) STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients. Frontiers in Immunology 11.
Crossref
Crossref
Ainhoa Arana Echarri, Mark Beresford, John P. Campbell, Robert H. Jones, Rachel Butler, Kenneth J. Gollob, Patricia C. Brum, Dylan Thompson & James E. Turner. (2021) A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling. Frontiers in Immunology 11.
Crossref
Crossref
Rebekka Weber, Christopher Groth, Samantha Lasser, Ihor Arkhypov, Vera Petrova, Peter Altevogt, Jochen Utikal & Viktor Umansky. (2021) IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cellular Immunology 359, pages 104254.
Crossref
Crossref
Daniele Santini, Giulia Ribelli, Sonia Simonetti, Michele Iuliani, Francesco Pantano & Giuseppe Tonini. 2021. Practical Medical Oncology Textbook. Practical Medical Oncology Textbook
365
380
.
Boopathi Subramaniyan, Sangita Sridharan, Cory M. Howard, Augustus M.C. Tilley, Tupa Basuroy, Ivana de la Serna, Elke Butt & Dayanidhi Raman. (2020) Role of the CXCR4-LASP1 Axis in the Stabilization of Snail1 in Triple-Negative Breast Cancer. Cancers 12:9, pages 2372.
Crossref
Crossref
Paola De Cicco, Giuseppe Ercolano & Angela Ianaro. (2020) The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. Frontiers in Immunology 11.
Crossref
Crossref
Veronica Mendoza-Reinoso, Laurie K. McCauley & Pierrick G.J. Fournier. (2020) Contribution of Macrophages and T Cells in Skeletal Metastasis. Cancers 12:4, pages 1014.
Crossref
Crossref
Vera Mayhew, Tolu Omokehinde & Rachelle W. Johnson. (2019) Tumor dormancy in bone. Cancer Reports 3:1.
Crossref
Crossref
Julie A. Rhoades (Sterling)Rachelle W. Johnson & Conor C. Lynch. 2020. Principles of Bone Biology. Principles of Bone Biology
1335
1353
.
Ana S. Leal, Kayla Zydeck, Sarah Carapellucci, Lyndsey A. Reich, Di Zhang, Jessica A. Moerland, Michael B. Sporn & Karen T. Liby. (2019) Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models. npj Breast Cancer 5:1.
Crossref
Crossref
Zhang Kun, Gao Xin, Wang Tao, Zhao Chenglong, Wang Dongsheng, Tang Liang, Liu Tielong & Xiao Jianru. (2019) Tumor derived EDIL3 modulates the expansion and osteoclastogenesis of myeloid derived suppressor cells in murine breast cancer model. Journal of Bone Oncology 16, pages 100238.
Crossref
Crossref
Yu Cao, Yong-Hui Feng, Li-Wei Gao, Xiao-Ying Li, Quan-Xiu Jin, Yu-Ying Wang, Ying-Ying Xu, Feng Jin, Shi-Long Lu & Min-Jie Wei. (2019) Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo. International Immunopharmacology 70, pages 110-116.
Crossref
Crossref
Denise E. de Almeida Nagata, Eugene Y. Chiang, Suchit Jhunjhunwala, Patrick Caplazi, Vidhyalakshmi Arumugam, Zora Modrusan, Emily Chan, Mark Merchant, Lingyan Jin, David Arnott, F. Anthony Romero, Steven Magnuson, Karen E. Gascoigne & Jane L. Grogan. (2019) Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Cell Reports 27:1, pages 269-281.e4.
Crossref
Crossref
Lisha Xiang & Daniele Gilkes. (2019) The Contribution of the Immune System in Bone Metastasis Pathogenesis. International Journal of Molecular Sciences 20:4, pages 999.
Crossref
Crossref
Ying Wang, Peng Li, Bo Wang, Shuai Wang & Pinan Liu. (2019) Identification of myeloid-derived suppressor cells that have an immunosuppressive function in NF2 patients. Journal of Cancer Research and Clinical Oncology 145:2, pages 523-533.
Crossref
Crossref
Jaime Fornetti, Alana L Welm & Sheila A Stewart. (2018) Understanding the Bone in Cancer Metastasis. Journal of Bone and Mineral Research 33:12, pages 2099-2113.
Crossref
Crossref
Elizabeth Ahern, Mark J. Smyth, William C. Dougall & Michele W. L. Teng. (2018) Roles of the RANKL–RANK axis in antitumour immunity — implications for therapy. Nature Reviews Clinical Oncology 15:11, pages 676-693.
Crossref
Crossref
Julie A. Sterling & Rachelle W. Johnson. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
752
759
.
G. David Roodman & Theresa Guise. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
737
742
.
Min Lan, Xiao-Ping Zhu, Zhi-Yuan Cao, Jia-Ming Liu, Qing Lin & Zhi-Li Liu. (2018) Extracellular vesicles-mediated signaling in the osteosarcoma microenvironment: Roles and potential therapeutic targets. Journal of Bone Oncology 12, pages 101-104.
Crossref
Crossref
Francis Combes, Séan Mc Cafferty, Evelyne Meyer & Niek N. Sanders. (2018) Off-Target and Tumor-Specific Accumulation of Monocytes, Macrophages and Myeloid-Derived Suppressor Cells after Systemic Injection. Neoplasia 20:8, pages 848-856.
Crossref
Crossref
Denise Buenrostro, Kristin A. Kwakwa, Nicole E. Putnam, Alyssa R. Merkel, Joshua R. Johnson, James E. Cassat & Julie A. Sterling. (2018) Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner. Bone 113, pages 77-88.
Crossref
Crossref
Rebekka Weber, Viktor Fleming, Xiaoying Hu, Vasyl Nagibin, Christopher Groth, Peter Altevogt, Jochen Utikal & Viktor Umansky. (2018) Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors. Frontiers in Immunology 9.
Crossref
Crossref
Samantha S. Dykes, Veronica S. Hughes, Jennifer M. Wiggins, Henrietta O. Fasanya, Mai Tanaka & Dietmar Siemann. (2018) Stromal cells in breast cancer as a potential therapeutic target. Oncotarget 9:34, pages 23761-23779.
Crossref
Crossref
Daniel Ajona, Carolina Zandueta, Leticia Corrales, Haritz Moreno, María J. Pajares, Sergio Ortiz-Espinosa, Elena Martínez-Terroba, Naiara Perurena, Fernando J. de Miguel, Eloisa Jantus-Lewintre, Carlos Camps, Silvestre Vicent, Jackeline Agorreta, Luis M. Montuenga, Ruben Pio & Fernando Lecanda. (2018) Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects. American Journal of Respiratory and Critical Care Medicine 197:9, pages 1164-1176.
Crossref
Crossref
Jinlu Dai, Yi Lu, Hernan Roca, Jill M. Keller, Jian Zhang, Laurie K. McCauley & Evan T. Keller. (2017) Immune mediators in the tumor microenvironment of prostate cancer. Chinese Journal of Cancer 36:1.
Crossref
Crossref
Charli Dominguez, Kristen K. McCampbell, Justin M. David & Claudia Palena. (2017) Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer. JCI Insight 2:21.
Crossref
Crossref
Joseph P. Vanderburgh, Shanik J. Fernando, Alyssa R. Merkel, Julie A. Sterling & Scott A. Guelcher. (2017) Fabrication of Trabecular Bone-Templated Tissue-Engineered Constructs by 3D Inkjet Printing. Advanced Healthcare Materials 6:22, pages 1700369.
Crossref
Crossref
Andrew M K Law, Elgene Lim, Christopher J Ormandy & David Gallego-Ortega. (2017) The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. Endocrine-Related Cancer 24:4, pages R123-R144.
Crossref
Crossref
Deborah Veis Novack & Gabriel Mbalaviele. 2017. Myeloid Cells in Health and Disease. Myeloid Cells in Health and Disease
235
255
.
Ik Sun Kim & Xiang H.-F. Zhang. (2016) One microenvironment does not fit all: heterogeneity beyond cancer cells. Cancer and Metastasis Reviews 35:4, pages 601-629.
Crossref
Crossref
Omar Valero-Monroy, Gabriel Garcia-Cervantes, Luis F. Marquez-Corrales, Ana G. Leija-Montoya, Jorge Sandoval-Basilio, Gustavo Martinez-Coronilla, Mario A. Isiordia-Espinoza & Nicolas Serafin-Higuera. (2016) Myeloid derived suppressor cell: A new player in periodontal disease?. Medical Hypotheses 95, pages 35-38.
Crossref
Crossref
Hila Confino, Michael Schmidt, Margalit Efrati, Ilan Hochman, Viktor Umansky, Itzhak Kelson & Yona Keisari. (2016) Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG. Cancer Immunology, Immunotherapy 65:10, pages 1149-1158.
Crossref
Crossref
Denise Buenrostro, Patrick L. Mulcrone, Philip Owens & Julie A. Sterling. (2016) The Bone Microenvironment: a Fertile Soil for Tumor Growth. Current Osteoporosis Reports 14:4, pages 151-158.
Crossref
Crossref
Marilène Binsfeld, Joséphine Muller, Virginie Lamour, Kim De Veirman, Hendrik De Raeve, Akeila Bellahcène, Els Van Valckenborgh, Frédéric Baron, Yves Beguin, Jo Caers & Roy Heusschen. (2016) Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma. Oncotarget 7:25, pages 37931-37943.
Crossref
Crossref
Deborah Veis Novack & Gabriel Mbalaviele. (2016) Osteoclasts—Key Players in Skeletal Health and Disease. Microbiology Spectrum 4:3.
Crossref
Crossref
Rebecca Silbermann & Garson David Roodman. 2016. Osteoimmunology. Osteoimmunology
311
324
.
Antonios O. Aliprantis, Julia F. Charles & Mary C. Nakamura. 2016. Osteoimmunology. Osteoimmunology
5
23
.
Yoshiro MaruYoshiro Maru. 2016. Inflammation and Metastasis. Inflammation and Metastasis
305
346
.
Silvestre Vicent, Naiara Perurena, Ramaswamy Govindan & Fernando Lecanda. (2015) Bone Metastases in Lung Cancer. Potential Novel Approaches to Therapy. American Journal of Respiratory and Critical Care Medicine 192:7, pages 799-809.
Crossref
Crossref
Laura E. Edgington-Mitchell, Jai Rautela, Hendrika M. Duivenvoorden, Krishnath M. Jayatilleke, Wouter A. van der Linden, Martijn Verdoes, Matthew Bogyo & Belinda S. Parker. (2015) Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer. Oncotarget 6:29, pages 27008-27022.
Crossref
Crossref
Parvin Forghani & Edmund K. Waller. (2015) Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer. Breast Cancer Research and Treatment 153:1, pages 21-30.
Crossref
Crossref
Nikola Baschuk, Jay Rautela & Belinda S Parker. (2015) Bone specific immunity and its impact on metastasis. BoneKEy Reports 4.
Crossref
Crossref
James R. Edwards. 2015. Bone Cancer. Bone Cancer
55
63
.
Pierrick G.J. Fournier, Patricia Juárez & Theresa A. Guise. 2015. Bone Cancer. Bone Cancer
13
28
.
Rachelle W. Johnson, Alyssa R. Merkel, Jonathan M. Page, Nazanin S. Ruppender, Scott A. Guelcher & Julie A. Sterling. (2014) Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clinical & Experimental Metastasis 31:8, pages 945-959.
Crossref
Crossref
Leah M. Cook, Gemma Shay, Arturo Aruajo & Conor C. Lynch. (2014) Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases. Cancer and Metastasis Reviews 33:2-3, pages 511-525.
Crossref
Crossref
Julia F. Charles & Antonios O. Aliprantis. (2014) Osteoclasts: more than ‘bone eaters’. Trends in Molecular Medicine 20:8, pages 449-459.
Crossref
Crossref
Rama Garimella, Laurie Washington, Janalee Isaacson, Julian Vallejo, Madoka Spence, Ossama Tawfik, Peter Rowe, Marco Brotto & Raymond Perez. (2014) Extracellular Membrane Vesicles Derived from 143B Osteosarcoma Cells Contain Pro-Osteoclastogenic Cargo: A Novel Communication Mechanism in Osteosarcoma Bone Microenvironment. Translational Oncology 7:3, pages 331-340.
Crossref
Crossref
Sam W.Z. Olechnowicz & Claire M. Edwards. (2014) Contributions of the Host Microenvironment to Cancer-Induced Bone Disease. Cancer Research 74:6, pages 1625-1631.
Crossref
Crossref
Julie A Sterling. (2014) Cancer and bone disease (ASBMR 2013). IBMS BoneKEy 11.
Crossref
Crossref
Denise Buenrostro, Serk In Park & Julie A. Sterling. (2014) Dissecting the Role of Bone Marrow Stromal Cells on Bone Metastases. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Natasa Kovacic, Peter I. Croucher & Michelle M. McDonald. (2013) Signaling Between Tumor Cells and the Host Bone Marrow Microenvironment. Calcified Tissue International 94:1, pages 125-139.
Crossref
Crossref
Da-Chuan Wang, Hai-Feng Wang & Ze-Nong Yuan. (2013) Runx2 induces bone osteolysis by transcriptional suppression of TSSC1. Biochemical and Biophysical Research Communications 438:4, pages 635-639.
Crossref
Crossref
Anandi Sawant & Selvarangan Ponnazhagan. (2013) Myeloid-Derived Suppressor Cells as Osteoclast Progenitors: A Novel Target for Controlling Osteolytic Bone Metastasis. Cancer Research 73:15, pages 4606-4610.
Crossref
Crossref
Chloe Constantinou & Ian S Fentiman. (2013) Inflammation and breast cancer. Breast Cancer Management 2:4, pages 311-325.
Crossref
Crossref
. (2013) The role of MDSCs in bone metastasis and cancer-related
osteolysis. BoneKEy Reports 2.
Crossref
Crossref
Claire L. Ihle, Sabrina J. Wright-Hobart & Philip Owens. (2022) Therapeutics Targeting the Metastatic Breast Cancer Bone Microenvironment. SSRN Electronic Journal.
Crossref
Crossref